Christos Emmanouilides

Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade,…

Journal of Clinical Oncology · 2002 · 894 citations

Palifermin for oral mucositis after intensive therapy for hematologic cancers

New England Journal of Medicine · 2004 · Last of 17 authors · 637 citations